Most of the 38 million people living with diabetes in the U.S. use daily injections or insulin pumps to keep glucose at safe levels — but a new study suggests that inhalers could be just as effective.
Most of the 38 million people living with diabetes in the U.S. use daily injections or insulin pumps to keep glucose at safe levels — but new research suggests that a third option could be just as effective. In a study led by Dr. Irl B. Hirsch, M.D., medical director of the Diabetes Care Center of the University of Washington Medical Center, an inhaled form of insulin — similar to an asthma inhaler — worked just as well as injections or pumps to control type 1 diabetes.
With pumps, people must wear the device, which can lead to skin problems. They also have to purchase extra accessories. Blood glucose levels can also drop with exercise, Hirsch warned, which can be problematic. 'Injections overall can be more convenient for some, but they don’t do as well as pump patients,' he said. With Afrezza, the product is inhaled into the lungs before meals, and the fast-acting insulin minimizes the glucose spike often seen after eating, Hirsch noted.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
If you own a Hyundai you can get new anti-theft software this weekend and here's how:If you own a Hyundai there's a way to protect your vehicle from thieves and it's free.Officials said it's a simple fix for a major problem.'This is a very effec
Read more »
Inhaled Insulin Could Help Folks With Type 1 Diabetes Avoid NeedlesInhaled insulin could be a better option than injections or pumps for some patients with type 1 diabetes, a new clinical trial shows.
Read more »
FDA advisers weigh benefits of weekly insulin for people with diabetesMost types of insulin therapy, an important part of diabetes treatment for many people, are given as daily injections to help manage blood sugar levels.
Read more »
Continuous Glucose Monitors Should Not Be NormalizedAre continuous glucose monitors beneficial for patients with diabetes who are not treated with insulin, or even for patients with prediabetes or obesity?
Read more »
Inhaled Insulin Plus Degludec an Option for Type 1 DiabetesUse of premeal Afrezza insulin plus long-acting degludec insulin was non-inferior to automated insulin delivery or multiple daily-injection regimens, but it isn't for everyone.
Read more »
Oral insulin drops offer relief for diabetes patientsDiabetes rates continue to rise. Scientists have now created a pain-free drug delivery method to help people with diabetes manage the disease and maintain their health more easily.
Read more »